Copy to clipboard 
Zimmer Biomet entered into a three-year agreement with the Hospital for Special Surgery (HSS) to create the HSS/Zimmer Biomet Innovation Center for Artificial Intelligence (AI) in Robotic Joint Replacement. The entities seek to develop new decision support tools, powered by data collection and machine learning, to provide data-driven recommendations to surgeons for robotic-assisted joint surgery.
The decision support tools, which will be integrated into the ROSA® Knee and ROSA® Hip systems, will further expand the capabilities of ZB’s ZBEdge™ suite of smart, digital and robotic technologies designed to deliver transformative data-powered clinical insights with the goal of improving patient outcomes.
Over the course of the collaboration, a team of HSS surgeons and ZB data scientists will develop and test hypotheses that use data-driven insights to address common clinical challenges associated with joint replacement. The goal is to use the validated hypotheses to inform the development of algorithms for decision support tools.
“Forging a multi-year collaboration with a leading orthopedics institution combines HSS’ clinical expertise with Zimmer Biomet’s expertise in surgical robotics and AI modeling,” said Ivan Tornos, Chief Operating Officer at Zimmer Biomet. “This agreement, which is our second collaboration with HSS in two years, advances our vision to accelerate impactful innovation through strategic third-party relationships.”
In 2022, Zimmer Biomet and HSS announced an exclusive agreement to deploy and commercialize HSS Orthopedic Care Pathways on Zimmer Biomet’s mymobility® with Apple Watch® remote care management platform. HSS Orthopedic Care Pathways comprise customized patient content created by HSS healthcare professionals, including pre- and post-operative care protocols, exercises, surveys, questionnaires, education materials and clinical parameters.
Zimmer Biomet’s mymobility with Apple Watch remote care management platform.
Speaking of the new partnership, Louis A. Shapiro, President and CEO at HSS said, “Through this unique collaboration, HSS can apply our knowledge and expertise to transform musculoskeletal care with innovative technologies that can improve clinical outcomes, patient experience and cost efficiency in a meaningful way.”
“Together we hope to create clinically validated decision support tools that rely on real-world patient and procedural data to inform actionable recommendations that help surgeons achieve predictable and reproducible clinical outcomes,” said Nitin Goyal, MD, Chief Science, Technology and Innovation Officer at Zimmer Biomet.
Source: Zimmer Biomet
Zimmer Biomet entered into a three-year agreement with the Hospital for Special Surgery (HSS) to create the HSS/Zimmer Biomet Innovation Center for Artificial Intelligence (AI) in Robotic Joint Replacement. The entities seek to develop new decision support tools, powered by data collection and machine learning, to provide data-driven...
Zimmer Biomet entered into a three-year agreement with the Hospital for Special Surgery (HSS) to create the HSS/Zimmer Biomet Innovation Center for Artificial Intelligence (AI) in Robotic Joint Replacement. The entities seek to develop new decision support tools, powered by data collection and machine learning, to provide data-driven recommendations to surgeons for robotic-assisted joint surgery.
The decision support tools, which will be integrated into the ROSA® Knee and ROSA® Hip systems, will further expand the capabilities of ZB’s ZBEdge™ suite of smart, digital and robotic technologies designed to deliver transformative data-powered clinical insights with the goal of improving patient outcomes.
Over the course of the collaboration, a team of HSS surgeons and ZB data scientists will develop and test hypotheses that use data-driven insights to address common clinical challenges associated with joint replacement. The goal is to use the validated hypotheses to inform the development of algorithms for decision support tools.
“Forging a multi-year collaboration with a leading orthopedics institution combines HSS’ clinical expertise with Zimmer Biomet’s expertise in surgical robotics and AI modeling,” said Ivan Tornos, Chief Operating Officer at Zimmer Biomet. “This agreement, which is our second collaboration with HSS in two years, advances our vision to accelerate impactful innovation through strategic third-party relationships.”
In 2022, Zimmer Biomet and HSS announced an exclusive agreement to deploy and commercialize HSS Orthopedic Care Pathways on Zimmer Biomet’s mymobility® with Apple Watch® remote care management platform. HSS Orthopedic Care Pathways comprise customized patient content created by HSS healthcare professionals, including pre- and post-operative care protocols, exercises, surveys, questionnaires, education materials and clinical parameters.
Zimmer Biomet’s mymobility with Apple Watch remote care management platform.
Speaking of the new partnership, Louis A. Shapiro, President and CEO at HSS said, “Through this unique collaboration, HSS can apply our knowledge and expertise to transform musculoskeletal care with innovative technologies that can improve clinical outcomes, patient experience and cost efficiency in a meaningful way.”
“Together we hope to create clinically validated decision support tools that rely on real-world patient and procedural data to inform actionable recommendations that help surgeons achieve predictable and reproducible clinical outcomes,” said Nitin Goyal, MD, Chief Science, Technology and Innovation Officer at Zimmer Biomet.
Source: Zimmer Biomet
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
